Comparison Pharming Group N.V. (PHAR) with Competitors
Pharming Group N.V. (PHAR) industry is Biotechnology.
Profit Margin
PHAR-7.20%
Industry-0.77%
Upside-6.43%
Operating Margin
PHAR-7.30%
Industry-2055.25%
Upside+2047.95%
Debt-to-Equity
PHAR43.21%
Industry28.27%
Upside+52.84%
Free Cash Flow Yield
PHAR5.33%
Industry-1.75%
Upside+7.07%
P/E
PHAR75.03
Industry-20.52
Upside+9554.23%
Forward P/E
PHAR23.70
Industry16.35
Upside+44.96%
P/S
PHAR2.55
Industry10.01
Upside-74.49%
P/B
PHAR3.52
Industry5.15
Upside-31.55%